{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:48:21Z","timestamp":1790866101509,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":2547,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.rmed.2006.01.002","type":"journal-article","created":{"date-parts":[[2006,2,15]],"date-time":"2006-02-15T07:21:06Z","timestamp":1139988066000},"page":"1566-1572","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Long-term moxifloxacin in complicated tuberculosis patients with adverse reactions or resistance to first line drugs"],"prefix":"10.1016","volume":"100","author":[{"given":"Luigi Ruffo","family":"Codecasa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Ferrarese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Antonietta","family":"Morandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Penati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Lacchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Vaccarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Battista","family":"Migliori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20133","key":"10.1016\/j.rmed.2006.01.002_bib1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1472-9792(02)00058-6","article-title":"The global situation of MDR-TB","volume":"83","author":"Espinal","year":"2003","journal-title":"Tuberculosis (Edinburgh)"},{"issue":"19","key":"10.1016\/j.rmed.2006.01.002_bib2","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1001\/jama.283.19.2537","article-title":"Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries","volume":"283","author":"Espinal","year":"2000","journal-title":"J Am Med Assoc"},{"issue":"10","key":"10.1016\/j.rmed.2006.01.002_bib3","first-page":"858","article-title":"Frequency of recurrence among MDR-tB cases \u2018successfully\u2019 treated with standardised short-course chemotherapy","volume":"6","author":"Migliori","year":"2002","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"10.1016\/j.rmed.2006.01.002_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1164\/rccm.2205007","article-title":"Studies of the early bactericidal activity of new drugs for tuberculosis: a help or a hindrance to antituberculosis drug development?","volume":"166","author":"O\u2019Brien","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"RR-11","key":"10.1016\/j.rmed.2006.01.002_bib5","first-page":"1","article-title":"Treatment of tuberculosis","volume":"52","year":"2003","journal-title":"MMWR Recomm Rep"},{"issue":"9407","key":"10.1016\/j.rmed.2006.01.002_bib6","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0140-6736(04)15496-2","article-title":"Programmes and principles in treatment of multidrug-resistant tuberculosis","volume":"363","author":"Mukherjee","year":"2004","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.rmed.2006.01.002_bib7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000081707","article-title":"Action of fluoroquinolones and Linezolid on logarithmic- and stationary-phase culture of Mycobacterium tuberculosis","volume":"50","author":"Garcia-Tapia","year":"2004","journal-title":"Chemotherapy"},{"issue":"7","key":"10.1016\/j.rmed.2006.01.002_bib8","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S0149-2918(04)90170-1","article-title":"Safety profile of oral and intravenous moxifloxacin: cumulative data from clinical trials and postmarketing studies","volume":"26","author":"Ball","year":"2004","journal-title":"Clin Ther"},{"issue":"3","key":"10.1016\/j.rmed.2006.01.002_bib9","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1056\/NEJM200107193450303","article-title":"The treatment of multidrug-resistant tuberculosis in Turkey","volume":"345","author":"Tahaoglu","year":"2001","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.rmed.2006.01.002_bib10","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1183\/09031936.01.17406410","article-title":"Sparfloxacin in the treatment of drug resistant tuberculosis or intolerance of first line therapy","volume":"17","author":"Lubasch","year":"2001","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.rmed.2006.01.002_bib11","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/j.1365-2133.2003.05582.x","article-title":"A randomized controlled trial (volunteer study) of sitafloxacin, enoxacin, levofloxacin and sparfloxacin phototoxicity","volume":"149","author":"Dawe","year":"2003","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.rmed.2006.01.002_bib12","first-page":"39","article-title":"Clinical use of Levofloxacin in the long-term treatment of drug resistant tuberculosis","volume":"57","author":"Richeldi","year":"2002","journal-title":"Monaldi Arch Chest Dis"},{"issue":"4","key":"10.1016\/j.rmed.2006.01.002_bib13","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1378\/chest.124.4.1476","article-title":"Comparative roles of levofloxacin and ofloxacin in the treatment of multidrug-resistant tuberculosis: preliminary results of a retrospective study from Hong Kong","volume":"124","author":"Yew","year":"2003","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.rmed.2006.01.002_bib14","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0924-8579(02)00239-X","article-title":"In vitro activity of moxifloxacin, levofloxacin, gatifloxacin and linezolid against Mycobacterium tuberculosis","volume":"20","author":"Rodriguez","year":"2002","journal-title":"Int J Antimicrob Agents"},{"issue":"11","key":"10.1016\/j.rmed.2006.01.002_bib15","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1164\/rccm.200305-682OC","article-title":"The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis","volume":"168","author":"Gosling","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.rmed.2006.01.002_bib16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1179\/joc.2003.15.1.66","article-title":"Long-term tolerance and effectiveness of moxifloxacin therapy for tuberculosis: preliminary results","volume":"15","author":"Valerio","year":"2003","journal-title":"J Chemother"},{"issue":"1","key":"10.1016\/j.rmed.2006.01.002_bib17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1183\/09031936.03.00047402","article-title":"Monitoring the quality of laboratories and the prevalence of resistance to antituberculosis drugs: Italy, 1998\u20132000","volume":"21","author":"Migliori","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2006.01.002_bib18","unstructured":"Maher D, Chaulet P, Spinaci S, Harries A. Treatment of tuberculosis: guidelines for national programmes, 3rd ed. Geneva, Switzerland, 2003."},{"issue":"1","key":"10.1016\/j.rmed.2006.01.002_bib19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2807\/esm.03.01.00110-en","article-title":"Surveillance of tuberculosis in the WHO European region in 1995: results of the feasibility study","volume":"3","author":"Veen","year":"1998","journal-title":"Euro Surveill"},{"issue":"8","key":"10.1016\/j.rmed.2006.01.002_bib20","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1056\/NEJM199302253280802","article-title":"Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin","volume":"328","author":"Goble","year":"1993","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.rmed.2006.01.002_bib21","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/AAC.48.3.780-782.2004","article-title":"Early bactericidal activity of moxifloxacin in treatment of pulmonary tuberculosis: a prospective, randomized study","volume":"48","author":"Pletz","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.rmed.2006.01.002_bib22","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1086\/424849","article-title":"Selection of a moxifloxacin dose that suppresses drug resistance in Mycobacterium tuberculosis, by use of an in vitro pharmacodynamic infection model and mathematical modeling","volume":"190","author":"Gumbo","year":"2004","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.rmed.2006.01.002_bib23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/00365540410019390","article-title":"Recurrent tendinitis after treatment with two different fluoroquinolones","volume":"36","author":"Burkhardt","year":"2004","journal-title":"Scand J Infect Dis"},{"issue":"5","key":"10.1016\/j.rmed.2006.01.002_bib24","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0149-2918(98)80074-X","article-title":"Multicenter comparative trial of ciprofloxacin versus cefuroxime axetil in the treatment of acute rhinosinusitis in a primary care setting. Rhinosinusitis Investigation Group","volume":"20","author":"Weis","year":"1998","journal-title":"Clin Ther"},{"issue":"4","key":"10.1016\/j.rmed.2006.01.002_bib25","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/00003226-199707000-00008","article-title":"Deposits of topical norfloxacin in the treatment of bacterial keratitis","volume":"16","author":"Castillo","year":"1997","journal-title":"Cornea"},{"key":"10.1016\/j.rmed.2006.01.002_bib26","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1378\/chest.128.5.3398","article-title":"A randomized trial comparing the cardiac rhythm safety of moxifloxacin vs levofloxacin in elderly patients hospitalized with community-acquired pneumonia","volume":"128","author":"Morganroth","year":"2005","journal-title":"Chest"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611106000072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611106000072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T10:17:23Z","timestamp":1760609843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611106000072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0954611106000072"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2006.01.002","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term moxifloxacin in complicated tuberculosis patients with adverse reactions or resistance to first line drugs","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2006.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}